Skip to content
Search

Latest Stories

BREAKING: MHRA recalls Picato 150 mcg/g and 500 mcg/g gel

The Medicines and Health products Regulatory Agency (MHRA) today issued a class 2 medicines recall for Picato 150 mcg/g and 500 mcg/g gel.

LEO Pharma is recalling all unexpired stock of the products from pharmacies and wholesalers as a precautionary measure due to concerns on the possible risk of skin malignancy.


This is following the suspension of the marketing authorisation of Picato (ingenol mebutate), while the investigations are ongoing.

“Stop prescribing Picato and consider other treatment options as appropriate. For patients who have recently been prescribed Picato, advise patients to be vigilant for any skin lesions developing and to seek medical advice promptly should any occur,” the government agency advised healthcare professionals.

Pharmacists are asked to stop supplying the products immediately, quarantine remaining stock and return it to the supplier using the approved process.

Healthcare professionals are also asked to report any suspected adverse reactions via Yellow Card Scheme www.mhra.gov.uk/yellowcard or MHRA Yellow Card app.

Product details:

ProductMarketing Authorisation Number
Picato 150 mcg/g gel ▼EU/1/12/796/001
Picato 500 mcg/g gel ▼EU/1/12/796/002
Batch NumberExpiry DatePack SizeFirst Distributed
A69570AJan-203 x 0.47g tubes18-Apr-18
A69570BJan-203 x 0.47g tubes06-Jun-18
A72947AFeb-203 x 0.47g tubes06-Jun-18
A75024AApr-203 x 0.47g tubes18-Jul-18
A78808AMay-203 x 0.47g tubes05-Sep-18
A80602BJun-203 x 0.47g tubes12-Sep-18
A80602AJun-203 x 0.47g tubes12-Sep-18
A89440ANov-203 x 0.47g tubes22-Jan-19
A92248ADec-203 x 0.47g tubes11-Feb-19
A98938AMar-213 x 0.47g tubes16-May-19
C01098AApr-213 x 0.47g tubes24-Jun-19
C10894AAug-213 x 0.47g tubes22-Oct-19
C14179AOct-213 x 0.47g tubes06-Dec-19
A76669AApr-202 x 0.47g tubes22-Aug-18
A88113AOct-202 x 0.47g tubes11-Dec-18
A98419AMar-212 x 0.47g tubes16-May-19
C03413AMay-212 x 0.47g tubes29-Aug-19
C11902ASep-212 x 0.47g tubes08-Nov-19

More For You

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

Chronic inflammation is linked to more than 50 per cent of all deaths worldwide and one in five cancers.

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

When Hemant Patel was struck down by Covid, he was determined to discover what was it that led to the disease having a devastating impact on the lives of people who seemed be healthy – the culmination of his journey is the book, The Complete Anti-Inflammatory Guide.

“I was gasping for breath and counting the number of days I might be alive when I was infected with Covid,” reveals Patel.

Keep ReadingShow less
Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less